← FDA Drug Approvals (Drugs@FDA)

LANSOPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2017-09-28

Drug application

FDA Application #

ANDA207156

Application type

Abbreviated New Drug Application (Generic)

Brand name

LANSOPRAZOLE

Generic name

Lansoprazole

Active ingredients

LANSOPRAZOLE

Dosage form

CAPSULE, DELAYED REL PELLETS

Route

ORAL

Marketing status

Prescription

Sponsor

CHARTWELL MOLECULAR

First approval

2017-09-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown